--- title: "Pre-market hot trades in US stocks: Star Fashion Culture pre-market down 8.75%; Ensysce Biosciences pre-market down 8.52%" type: "News" locale: "en" url: "https://longbridge.com/en/news/286888137.md" description: "Star Fashion Culture pre-market down 8.75%; Ensysce Biosciences pre-market down 8.52%; Amesite pre-market up 205.30%; Meiwukeji pre-market up 186.31%; MetaVia pre-market up 84.56%" datetime: "2026-05-19T09:42:27.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286888137.md) - [en](https://longbridge.com/en/news/286888137.md) - [zh-HK](https://longbridge.com/zh-HK/news/286888137.md) --- # Pre-market hot trades in US stocks: Star Fashion Culture pre-market down 8.75%; Ensysce Biosciences pre-market down 8.52% **Popular Pre-Market Trades in US Stocks** Star Fashion Culture, down 8.75% in pre-market trading, has no significant news recently. The trading is active, with clear capital flows. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. Ensysce Biosciences is down 8.52% in pre-market trading. Based on recent key news: 1. On May 15, Ensysce Biosciences released its first-quarter financial report, with net losses widening to $3.6 million, reduced cash flow, and increased R&D expenses, putting pressure on the stock price. 2. On May 15, the company announced the formal review of strategic alternatives, including potential collaborations and licensing agreements, which the market reacted poorly to, causing the stock price to drop. 3. On May 15, the PF614-301 Phase III trial reached 50% of its mid-term enrollment target and received IRB approval to start the third part of PF614-MPAR-102, but due to increased R&D costs, the stock price continued to decline. Increased R&D costs and reduced cash flow led to a negative market reaction. **Top Gainers in Pre-Market Trading in US Stocks** Amesite is up 205.30% in pre-market trading. Based on recent key news: 1. On May 19, Amesite CEO Ann Marie Sastry purchased 174,216 shares of common stock at $1.44 per share. This move increased market confidence in the company's future development, driving the stock price significantly higher. Source: EDGAR system. 2. On May 19, director George Parmer purchased 243,902 shares of common stock, also at $1.44 per share. This further enhanced investor trust in the company's management, promoting the stock price increase. Source: EDGAR system. 3. On May 19, Amesite reduced cash consumption through layoffs and internalization, focusing on product development of AI tools and shifting to monthly service contracts, improving operational efficiency. This strategic adjustment improved market expectations, supporting the stock price increase. Source: SEC 10-Q report. The transformation in the AI industry is accelerating, with significant capital inflows. Meitu Technology is up 186.31% in pre-market trading, with no significant news recently. The trading is active, with clear capital flows. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. MetaVia is up 84.56% in pre-market trading. MetaVia's pre-market gain is significant, 1. On May 18, MetaVia released a major product update, driving the stock price significantly higher. The company announced the launch of new products through PR Newswire, and the market reacted positively, with the stock price rising 84.56% in pre-market trading. 2. On May 17, MetaVia received support from important investors, enhancing market confidence. Investors expressed optimism about the company's future growth potential, leading to the stock price increase On May 16th, the overall industry improved, and technology stocks generally rose. Macroeconomic data supports the development of the technology sector, and MetaVia benefits from industry trends, with its stock price continuing to rise. The technology sector has performed strongly recently, with significant capital inflows ### Related Stocks - [STFS.US](https://longbridge.com/en/quote/STFS.US.md) - [ENSC.US](https://longbridge.com/en/quote/ENSC.US.md) - [AMST.US](https://longbridge.com/en/quote/AMST.US.md) - [WNW.US](https://longbridge.com/en/quote/WNW.US.md) - [MTVA.US](https://longbridge.com/en/quote/MTVA.US.md) ## Related News & Research - [Ensysce Biosciences GAAP EPS of -$0.52 beats by $0.21](https://longbridge.com/en/news/286613093.md) - [These 3 AI ETFs Could Be the First to Kill the Stock Market Rally](https://longbridge.com/en/news/286933151.md) - [Should you invest $1,000 in AGNC Investment right now?](https://longbridge.com/en/news/286802595.md) - [PAULSON: RISKS ARE "SUPER-ELEVATED" RIGHT NOW TO BOTH INFLATION AND THE OUTLOOK](https://longbridge.com/en/news/286977620.md) - [TGT Stock Alert: What to Know as Target Taps Former Walmart Exec](https://longbridge.com/en/news/286957668.md)